Ingenol disoxate - PharmaKB

Ingenol disoxate

Ingenol disoxate is a small molecule pharmaceutical. It is currently being investigated in clinical studies.

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

13 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

No data

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Actinic keratosis	D055623	—	L57.0	6	4	5	—	—	12
Keratosis	D007642	—	—	6	4	5	—	—	12
Carcinoma	D002277	—	C80.0	—	—	1	—	—	1
Squamous cell carcinoma	D002294	—	—	—	—	1	—	—	1
Squamous cell neoplasms	D018307	—	—	—	—	1	—	—	1

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Acne vulgaris	D000152	EFO_0003894	L70	—	1	—	—	—	1

Indications Phases 1

No data

Indications Without Phase

No data

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	Ingenol disoxate
INN	ingenol disoxate
Description	Ingenol disoxate is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Classification	Small molecule
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	CCc1noc(CC)c1C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C